AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

OCT in Diagnosis of Irregular Corneas

Recruitingn/aAges 14 Years - 85 YearsAllOregon Health and Science University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This main goal of this study is to improve the detection, classification, monitoring, and treatment of irregular corneas due to keratoconus, warpage, dry eye, scar, stromal dystrophies, and other corneal conditions. The primary goal will be achieved by using optical coherence tomography (OCT) to: 1. Develop an OCT-based system to classify and evaluate corneal-shape irregularities. 2. Develop OCT metrics for more sensitive detection of keratoconus progression. 3. Develop OCT-and-topography guided phototherapeutic keratectomy (PTK) for irregular corneas.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: GROUP A: * Keratoconus: 1. CDVA โ‰ฅ 20/25 in the better eye; and both of the following in the worse eye 2. Topography characteristic of keratoconus or pellucid marginal degeneration * Contact lens-related corneal warpage: 1. Contact lens use; and 2. Topography irregularities * Dry eye: 1. Symptoms of dry eye documented by Ocular Surface Disease Index (OSDI) questionnaire score โ‰ฅ 30; and 2. Topography irregularities 3. Presence of punctate epithelial erosion on exam with surface staining 4. Aqueous deficiency or evaporative dry eye * Epithelial basement membrane dystrophy (EBMD): 1. Negative corneal fluorescein staining; and 2. Corneal opacities; and 3. Topography irregularities * Stromal addition or subtraction: 1. Scars; or 2. Salzmann's degeneration; or 3. Stromal dystrophies; or 4. Complication (visual complaints) after LASIK or photorefractive keratectomy (PRK) * Stromal distortion: 1. Radial keratectomy (RK); or 2. Corneal transplants. * Normal controls: 1. Healthy eyes with no previous eye procedures/surgeries. GROUP B: Participants will be selected from the keratoconus population in Group A based on topography findings. GROUP C: Participants will be selected from the stromal addition/subtraction and stromal distortion populations of Group A if they have vision primarily limited by scars, dystrophy, or high astigmatism that could benefit from PTK. Exclusion Criteria (all groups): * Inability to give informed consent. * Inability to maintain fixation for OCT imaging. * Inability to commit to required study visits. * Eyes with concurrent cataract, retinal disease, glaucoma, or other eye conditions that may limit the visual outcome after surgery. * Previous corneal surgeries if considered as a keratoconus participant. * Pregnancy or breastfeeding.
๐Ÿ’Š

What it tests

  • Optical Coherence Tomography
๐Ÿ“

Where

1 site
Humberto Martinez
Portland, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy